A Single-arm, Open-label Clinical Study to Evaluate the Efficacy and Safety of VRT106 in Combination With Chemotherapy for Resectable Pancreatic Cancer

This study is testing whether a drug called VRT106 combined with chemotherapy is safe and effective as a treatment for people with pancreatic cancer that is still removable by surgery. **You may be eligible if...** - You are between 18 and 75 years old - You have been diagnosed with pancreatic cancer that can be surgically removed - You are in good health (ECOG score 0 or 1) with adequate organ function - Your expected survival is at least 6 months **You may NOT be eligible if...** - You have previously received treatment for pancreatic cancer (including other oncolytic virus therapies) - You have had an organ or stem cell transplant - You have a weakened immune system - You have a known drug or alcohol dependency - You are pregnant or breastfeeding Talk to your doctor to see if this trial is right for you.